Meeder Asset Management’s Fortress Biotech FBIO Stock Holding History

Meeder Asset Management’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-169	Closed	-$7K	–	2230
2020 Q2	$7K	Hold	169	–	–	﹤0.01%	1415
2020 Q1	$5K	Hold	169	–	–	﹤0.01%	1771
2019 Q4	$7K	Hold	169	–	–	﹤0.01%	1673
2019 Q3	$4K	Buy	169 +59	+54%	+$1.39K	﹤0.01%	1819
2019 Q2	$2K	Hold	110	–	–	﹤0.01%	1852
2019 Q1	$3K	Sell	110 -1,793	-94%	-$47K	﹤0.01%	1492
2018 Q4	$25K	Buy	1,903 +422	+28%	+$7.05K	﹤0.01%	1004
2018 Q3	$35K	Buy	1,481 +1,436	+3,191%	+$45.9K	﹤0.01%	884
2018 Q2	$2.02K	Sell	45 -20	-31%	-$1.13K	﹤0.01%	1414
2018 Q1	$4K	Buy	65 +42	+183%	+$2.66K	﹤0.01%	1273
2017 Q4	$1K	Hold	23	–	–	﹤0.01%	1565
2017 Q3	$2K	Sell	23 -36	-61%	-$2.43K	﹤0.01%	1450
2017 Q2	$4K	Hold	59	–	–	﹤0.01%	1250
2017 Q1	$3K	Sell	59 -61	-51%	-$2.73K	﹤0.01%	1253
2016 Q4	$5K	Buy	+120	New	+$4.49K	﹤0.01%	852

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Meeder Asset Management's FBIO Position: Q3 2020 in Review

Meeder Asset Management sold out of Fortress Biotech (FBIO) in Q3 2020, closing a stake of 169 shares — an estimated $7K sold.

Meeder Asset Management first reported a position in FBIO in Q4 2016 and held it in 15 quarters. The position peaked at $35K in Q3 2018. 77 funds tracked by Wall St. Rank hold FBIO as of Q3 2020.

Meeder Asset Management reported no remaining Fortress Biotech position as of Q3 2020 after selling out during the quarter.
Meeder Asset Management sold 169 Fortress Biotech shares in Q3 2020, an estimated $7K.
Meeder Asset Management first reported a position in Fortress Biotech in Q4 2016 and held it in 15 quarters.
Meeder Asset Management's Fortress Biotech position peaked at $35K in Q3 2018.
77 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2020.

Based on Meeder Asset Management's 13F filing for Q3 2020, filed 2 Nov 2020.